Efficacy and Safety of a Purified Standardised Bee Venom Preparation

Phase 3

Completed

• Conditions: Bee Venom Allergy

• Registration Number: NCT00263952
• Lead Sponsor: Allergopharma GmbH & Co. KG

Brief Summary

The trial is performed to assess efficacy and safety of a purified standardised bee venom preparation in bee venom allergy

Detailed Description

Not available

Study Timeline

• Study Start: 2003-03
• Primary Completion: 2005-01
• Study First Submitted: 2005-12-09
• Study First Submitted QC: 2005-12-09
• Study First Posted: 2005-12-12
• Study Completion: 2010-04
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-01
• Last Update Posted: 2013-03-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• History of bee venom allergy,
• Positive RAST for bee venom,
• Positive skin prick test for bee venom

Exclusion Criteria

• Serious chronic diseases

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

Allergopharma GmbH & Co. KG; 🇩🇪 Reinbek, Germany